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ABSTRACT: A facile method was used to synthesize biocomposites containing diﬀering ratios of hyaluronic acid (HA) and
cellulose (CEL). Based on the properties of the individual
polymers, the resultant composite materials may have potentially
great wound care properties. In the method outlined here, 1-butyl3-methylimidazolium chloride ([Bmim][Cl]), a simple ionic liquid,
was used as the sole solvent without chemical modiﬁers to dissolve
the biopolymers at ratios of 1:1 and 2:1 HA to CEL. This method
was completely recyclable since the ionic liquid, [Bmim][Cl], can
be recovered. Results from spectroscopic measurements [Fourier
transform infrared (FT-IR) and X-ray diﬀraction (XRD)] conﬁrm
the interaction between HA and CEL. Scanning electron
microscopy (SEM) images reﬂect diﬀering biopolymer ratios and
the resulting impact on the texture and porosity of these composite materials. The composites exhibited high swelling capacity in
various media. These composites were also drug-loaded to examine drug release properties for greater potential in combating
Staphylococcus aureus infections.

■

INTRODUCTION
Hyaluronic acid (HA) is a glycosaminoglycan that is found
throughout connective, endothelial, and neural tissues.1 It has
unique properties, such as high hygroscopicity, viscoelasticity,
biocompatibility, and nonimmunogenicity, and does not
generate toxic products upon degradation.2 These unique
properties are thought to be beneﬁcial in wound care bandage
materials as HA has been investigated for a number of clinical
applications, including lubrication and mechanical support of
arthritic joints,3,4 as a surgical aid in ophthalmological
surgery,5,6 drug delivery agent,7−9 and to facilitate surgical
wound healing.10−12 Hyaluronic acid has also recently been
used in skin-care products, such as facial moisturizers, as a
result of its aqueous viscous consistency and nonallergenic
tissue friendliness.13 However, one disadvantage of HA is its
lack of adequate mechanical properties.14 To overcome this
disadvantage, our laboratory focuses on the fabrication of
composites from HA and cellulose (CEL) in this manuscript.
Cellulose (CEL) is a polysaccharide and the primary
constituent of plant cell walls. It is biocompatible and
biodegradable. Cellulose was chosen for this study because it
lends chemical stability and mechanical strength to composite
materials.15 Diﬀerent forms of cellulose have recently been
used as additives in composite biopolymer fabrication. For
example, Huang et al. fabricated berberine-enriched carboxymethylcellulose−hyaluronic acid hydrogels with excellent
© 2020 American Chemical Society

viscosity to provide anti-inﬂammatory and antibacterial
functions for minimizing postsurgical complications. However,
these composites required polyvinyl alcohol as a base to assist
membrane formation.16 Jia et al. have shown that bacterial
cellulose (BC) and hyaluronic acid can be combined into
composites with enhanced tensile strength and Young’s
modulus.17 While BC has been widely used for various
applications, cellulose derived from cotton (as used in this
manuscript) is thermodynamically more stable than BC.18 In
addition, the fabrication of these composites required crosslinking reactions or soaking BC for several days in HA.17 In
another example, Domingues et al.19 determined that cellulose
nanocrystals and hyaluronic acid can be combined into
hydrogel materials for injectable purposes. However, these
materials also required the covalent modiﬁcation of HA and
CEL using additional cross-linkers.19
Tran et al.15 used ionic liquids (ILs) to combine chitosan
and cellulose into composite materials with enhanced tensile
strength, as well as antimicrobial properties. In addition,
materials reported by Tran et al. exhibited an increased
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Figure 1. FT-IR spectra of CEL, HA, 1:1, and 2:1 composites (a), and O−H stretching region (b).

biomedical use as wound care devices for minimizing bacterial
infections. The main advantages of this approach are the ease
of fabrication, cross-linking agents are not necessary, and high
swelling abilities of resulting composites. Preparation of these
biocomposites demonstrates promising applications as patches
for use in wound care.

antimicrobial eﬀect on a wider range of bacteria than other
chitosan-based materials.15,20,21 By fabrication of these
biopolymers into composite materials, we rationalize that the
combined properties of mechanical integrity, hygroscopicity,
and biocompatibility could be beneﬁcial for potential wound
care devices. To obtain these composites, we hypothesize that
the use of ionic liquids would be a viable and facile alternative
for dissolving biopolymers, such as HA and CEL, as compared
to previously mentioned procedures.
Ionic liquids (ILs) are organic salts that are liquid at
temperatures below 100 °C.22 ILs have various, unique
chemical and physical properties, including high thermal
stability, high solubility power, low volatility, and negligible
vapor pressure. Because of these properties, ILs have been
labeled as “green” alternatives to traditional, organic solvents.23
In addition, due to their high solvating ability, ILs have been
used as solvents in dissolving biopolymers, including cellulose,
extensively.15,24−27 However, limited information was found
regarding ILs to dissolve HA. For this reason, we explored ILs
as potential solvents for composite fabrication. In this study,
we demonstrate that a simple ionic liquid, 1-butyl-3methylimidazolium chloride ([Bmim][Cl]), solubilizes both
hyaluronic acid and cellulose and allows composite formation
without the use of chemical modiﬁcations or cross-linking
reactions. One anticipated challenge of [Bmim][Cl] is the high
viscosity associated with the halide anion,28 but viscosity was
not an issue with the elevated temperature needed for
fabrication. Overall, this method proved that it is simple,
green, and completely recyclable.
We also note that composites impregnated with antimicrobial agents may be used as topical medicated devices. Previous
studies support the use of antimicrobial group of uniform
materials based on organic salts (GUMBOS) as a chemical
approach for combating various Gram-negative and Grampositive bacteria.29,30 GUMBOS are a group of novel materials,
similar to ILs, composed of bulky inorganic and/or organic
counterions with melting points between 25 and 250 °C.31
GUMBOS employed in this manuscript were formulated from
chlorhexidine, an antiseptic, and β-lactam antibiotics, oxacillin
and cephalothin. These materials have been proven to be more
eﬀective than the constituent parent compounds against
various strains of bacteria, most notably Staphylococcus aureus,
which is one of the most common bacteria found on the skin
and hair, as well as noses and throats of humans and animals.32
This bacterium is capable of manifesting severe clinical
infections.
Herein, we explore the development and characterization of
a green and recyclable method using ionic liquids to fabricate
composites from biocompatible and biodegradable biopolymers (e.g., hyaluronic acid and cellulose) and exploit their

■

RESULTS AND DISCUSSION
FT-IR Analysis. FT-IR spectroscopy was employed to
determine the chemical structure of the composite materials.
Spectra were measured using a Bruker Tensor 27 (Billerica,
MA) under transmission wavenumber ranging from 650 to
4000 cm−1 (Figure 1a,b). The HA spectrum had absorption
bands at 1604 and 1405 cm−1. These are indicative bands of
the carboxylate asymmetric stretching vibration and carboxylate symmetric stretching, respectively.33 Bands at 1145 and
1027 cm−1 are C−O−C stretching vibration of the HA
skeleton.34 Two signals at 1560 and 1322 cm−1 are indicative
of amide bands.33 In the region of 1150−650 cm−1, there is
little diﬀerence between the spectra of the composites and HA.
This veriﬁes the presence of HA in these composite materials.
All spectra have a strong absorption band between 3600 and
3000 cm−1, which is indicative of the O−H stretching region
(Figure 1b). While these peaks are not as broad in composite
materials, they are broader than the cellulose O−H peak. This
narrow peak for cellulose is presumably due to hydrogen
bonding within the glucose monomer network. This change in
peak shape within the composites suggests hydrogen-bonding
interactions between the HA and cellulose in the composite
materials.35
Thermal Stability of Composites. Figure 2 displays the
thermogravimetric analysis (TGA) spectra for the parent
biopolymers and composite materials. TGA was performed
using a Hi Res modulated TGA 2950 thermogravimetric
analyzer (TA Instruments, New Castle, DE). Small pieces
weighing about 20 mg were placed in a platinum pan and

Figure 2. TGA spectra of cellulose, HA, and composites.
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heated from room temperature to 575 °C at a rate of 10 °C/
min. Onset temperatures were extrapolated and denote the
temperature at which the weight loss begins. Onset temperatures for cellulose and hyaluronic acid were 332.70 and
228.12 °C, respectively (Table 1). Onset temperatures of the

Table 2. Crystallinity Indices (%) of the Composites and
Parent Biopolymers

Table 1. Onset Temperatures of the Composites and Parent
Biopolymers
compound

onset temperature (°C)

hyaluronic acid
cellulose
1:1 composite
2:1 composite

228.1
332.7
324.3
305.4

Article

materials

crystallinity index (%)

hyaluronic acid
cellulose
1:1 composite
2:1 composite

N/A
85.9
78.1
76.6

network. The amorphous material disrupts the crystalline
lattice of the cellulose, thus lowering its CI
I − Iam
× 100%
CI % = 002
I002
(1)

composites decreased by 9 and 30 °C, as compared to those of
cellulose for 1:1 and 2:1, respectively. The 1:1 composite had
an onset temperature of 324.27 °C, while the 2:1 composite
had an onset temperature of 305.44 °C. The 2:1 composite
most likely had a lower degradation temperature due to the
higher concentration of HA, which is known to be a thermally
sensitive material.
X-ray Diﬀraction (XRD). X-ray diﬀraction was employed
to determine how the varying amount of HA aﬀects the
crystallinity of cellulose. XRD was performed using an
Empyrean X-ray diﬀractometer (Malvern Panalytical, U.K.).
Evaluation of data presented in Figure 3a conﬁrms that HA is
completely amorphous. The supramolecular structure of
ﬁbrous cellulose exists as cellulose I, and its crystallinity is a
result of a ratio between two forms (Iβ and Iα). As shown in
Figure 3, ﬁbrous cellulose has ﬁve characteristic peaks at 14.9,
16.4, 20.6, 22.7, and 34.5°, which corresponds to the 101, 101̅,
021, 002, and 040 planes, respectively.36,37 The crystallinity
pattern of ﬁbrous cellulose is more characteristic of a higher
concentration of cellulose Iβ than Iα, a ratio more prevalent in
woody plants and cotton, which is the origin of cellulose used
in this manuscript.18 In general, the composites maintain the
characteristic peaks of cellulose. However, there is a slight
increase in amorphous scattering between 14.9 and 22.7°
diﬀraction angles in both 1:1 and 2:1 composites.
Crystallinity indices (CIs) of these materials were
determined using the Segal method (eq 2), whereby I002 is
the intensity of the 002-lattice diﬀraction and Iam is the
intensity of diﬀraction at 2θ = 18°.37 The crystallinity indices
are presented in Table 2. According to eq 1, the CI of cellulose
is 85.9%. As shown in Table 2, CIs of both composites were
lower than that of cellulose with the 2:1 composite having the
lowest CI. This can be attributed to the higher content of
amorphous HA in relation to cellulose within the composite

Drug loading of the composites was also evaluated using XRD
(Figure S3). Moreover, powder XRD was employed to
elucidate the crystalline nature of [CHX][Oxa] and
amorphous nature of [CHX][Ceph] (Figure S4). There is
no obvious diﬀerence between the XRD spectra of plain
composites versus drug-loaded. However, there are slight
changes in the crystallinity indices, which were calculated for
drug-loaded composites (Table S1). [CHX][Oxa] had a larger
eﬀect on CI; for example, in 1:1 composites, [CHX][Oxa]
loading lowered the CI from 78.1 to 75.3%. This could
possibly be due to adsorption of the drug onto the surface of
the materials. In contrast, with 2:1 composites, [CHX][Oxa]
loading increased the CI from 76.6 to 77.9% as a result of
greater interactions of [CHX][Oxa] within the network of
these composites.
Scanning Electron Microscopy (SEM). Composites were
cut into small pieces, and the surfaces (before and after drug
loading) were spin-coated with a thin layer of conductive
platinum. Surface morphologies were evaluated by scanning
electron microscopy (Quanta 3D DualBeam FEG FIB-SEM,
FEI) at 5 kV. All images (Figure 4) are at 5000×. Highermagniﬁcation images can be found in the Supporting
Information (Figures S5 and S6). The composites exhibited
a textured, porous surface; however, for a 2:1 composite, the
pores were larger with more irregularity in shape. The ﬁbrous
networks of CEL and HA are clearly delineated within the
pores. Instead, the 1:1 composite exhibited a smoother, planar
texture. In comparison to the original materials, drug-loaded
composites also exhibited a smoother-looking surface,
indicating loading of the drug on the surface and in the
pores. As a result, the ﬁbrous networks were no longer
observable after drug loading of [CHX][Ceph] in both 1:1 and
2:1 composites. It is presumed that the loading of [CHX][Oxa] would also exhibit the same smooth-looking surface.

Figure 3. XRD spectra of CEL and HA (a), and 1:1 and 2:1 composites (b).
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Figure 4. Morphology of 1:1 composite (a), 2:1 composite (b), [CHX][Ceph]-loaded 1:1 composite (c), and [CHX][Ceph]-loaded 2:1
composite (d).

material decreased, the swelling increased. The high-density
network within 1:1 composites could prevent the absorption of
media, whereas the higher porosity within 2:1 materials
provides voids for more facile absorption. The higher ratio of
hygroscopic HA could also play a role in the absorption
capacity of 2:1 composites. A larger degree of swelling could
also be attributed to the higher concentration of sodium ions
on HA that may have aided in balancing the internal osmosis.39
Interestingly, all composites maintained structural integrity,
which can be attributed to the mechanical strength of cellulose.
Images of dry and swollen composites are found in the
Supporting Information (Figures S9 and S10). In comparison
to hydrogels fabricated by Domingues et al., the swelling of
composites synthesized in this manuscript was signiﬁcantly
higher.19 This could be due to no cross-linking agents used in
the fabrication process. Instead of creating physical cross-links,
this process is more akin to solution blending, thereby
maintaining the hygroscopic functional groups of HA. Fibrous
cellulose also has relatively higher absorbent properties, which
could make it a better choice for topical applications such as
wound management.40
Release Properties. The release of two antimicrobial
GUMBOS was determined spectrophotometrically in a 0.9%
saline solution at λ = 231 nm. The cumulative amount of drug
released and the percentage of drug released as a function of
time for [CHX][Ceph] and [CHX][Oxa] are shown in Figures
6 and 7, respectively. Upon the placement of composites into
the saline medium, an initial large amount of drug is released in
what is known as “burst release”.41 After the initial burst, the
rate at which drugs are released decreases and all drugs have
been released between 4 and 6 h. This is evident from the
stable plateau between the 4 and 6 h time point. Burst release
could be beneﬁcial for wound treatment as quick release could
ensure the rapid reduction of bacteria from wound sites.41−43
Overall, the 1:1 composite showed a much higher release of

Cross-sectional areas (before and after drug loading) were
also evaluated by SEM at 5 kV. These images can be found in
the Supporting Information (Figures S7 and S8). Crosssectional areas of composite materials (1:1 and 2:1) show no
discernable diﬀerence between the drug-loaded and nondrugloaded composites. However, 1:1 composites exhibited a
network of higher density within the matrix as compared to 2:1
composites. Similar to the surface, 2:1 composites exhibited a
much more porous network within the composite matrix.
Swelling Studies. Swelling studies were performed to
demonstrate the exudation capacity of these potential wound
care composites, as well as investigate the eﬀect of varying
polymer ratios on capacity. Swelling percentages are illustrated
in Figure 5. In all studied media, the 2:1 (HA/CEL) composite
had a much higher swelling than the 1:1 (HA/CEL) material.
These results indicate that the swelling ratio increased as the
pore size and amorphous nature of the composites increased as
amorphous regions are able to absorb more water than
crystalline regions.38 Moreover, evaluation of these results
indicates that as the density of ﬁbers within the composite

Figure 5. Swelling of composite materials in deionized water, 0.9%
saline, and 1× phosphate-buﬀered saline (PBS) (pH 7.4).
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Figure 6. Cumulative drug release (a) and percent drug release (b) for [CHX][Ceph].

Figure 7. Cumulative drug release (a) and percent drug release (b) for [CHX][Oxa].

the disks and composites, and the diameters were measured
using a ruler. The zone of inhibition is a circular area around
the disk (or composite) in which no bacteria has grown due to
susceptibility of the bacterium to the drug. The rate of drug
diﬀusion through agar can be governed by many diﬀerent
factors such as relative hydrophobicity, aqueous solubility,
molecular weight, and intrinsic resistance of the microorganism.45 These ZOI values conﬁrm that drug release
occurred from the composites into the agar. The 1:1 composite
loaded with [CHX][Ceph] had larger zone diameters than the
2:1 composite of the same drug (Table 3). However, an

drugs than the 2:1 ratio. In both drug release studies, the 1:1
composite exhibited quantitative drug release as shown in
Figures 6b and 7b. In contrast, the 2:1 material did not achieve
quantitative release over the same time period. This could be
attributed to the morphology of the surface and inner network
of the composites. The 1:1 composite, as seen in Figure 4a,
exhibits less pores than the 2:1 composite and a denser inner
network. Presumably, drug molecules are not physically able to
penetrate the 1:1 network as deeply and concentrate more on
the surface. In eﬀect, these drug molecules are then released
from the surface in a “burst” manner when placed into saline.
In contrast, the 2:1 composite exhibited a much more porous
surface (Figure 4b) and less dense inner network, which could
allow trapping of the drug further within the ﬁbrous network
and impede the rate and quantity of the release of organic
molecules. Both composites (1:1 and 2:1) released more
[CHX][Ceph] than [CHX][Oxa], which we hypothesize
could be a result of [CHX][Oxa] having a stronger interaction
with the composite material than [CHX][Ceph].
Drug-loaded and drug-released composites were also
evaluated using electron-dispersive X-ray spectroscopy (EDS)
to conﬁrm drug release (Quanta 3D DualBeam FEG FIB-SEM
with an EDAX Pegasus EDS/EBSD detector). GUMBOS
structures contain sulfur atoms (Figure S11). EDS spectra of
plain composites can be found in the Supporting Information
(Figures S12 and S13). After evaluation of drug-loaded
composites using EDS, it was conﬁrmed that the sulfurcontaining drugs were present in the loaded samples. We also
observed that the sulfur signal decreases in drug-released
samples (Figures S14−S16).
Disk Diﬀusion. Kirby−Bauer disk diﬀusion is a qualitative
susceptibility test used to determine the sensitivity or
resistance of a microorganism toward an antimicrobial
agent.44 In this study, disk diﬀusion was performed to
demonstrate drug release from composites onto an agar
surface. Three concentrations were loaded onto the disks and
composite rounds: 10, 50, and 250 μM. During incubation, the
drug diﬀuses from composites and disks into the agar. After
20−24 h incubation, zones of inhibition (ZOI) formed around

Table 3. Zone Diameters of Composites and Standard Disks
for Diﬀusion of [CHX][Ceph]
zones of Inhibition (mm ± standard deviation)
concentration (μM)

1:1 composite

2:1 composite

standard disk

10
50
250

15.7 ± 1.2
27.3 ± 1.5
36.3 ± 2.5

14.7 ± 0.6
25.7 ± 0.6
34.7 ± 1.5

17.6 ± 1.1
28.2 ± 1.0
37.3 ± 1.0

opposing trend was seen for zone diameters of [CHX][Oxa]
(Table 4). Overall, [CHX][Oxa] produced larger ZOIs versus
[CHX][Ceph]. This could be due to the higher susceptibility
of S. aureus to [CHX][Oxa] as the standard disks impregnated
with [CHX][Oxa] produced larger zone diameters than
[CHX][Ceph]. Moreover, it has been proven in previous
studies that the water solubility of [CHX][Oxa] is higher than
that of [CHX][Ceph], which allowed for better diﬀusion of
Table 4. Zone Diameters of Composites and Standard Disks
for Diﬀusion of [CHX][Oxa]
zones of Inhibition (mm ± standard deviation)

4129

concentration (μM)

1:1 composite

2:1 composite

standard disk

10
50
250

21.3 ± 0.6
31.7 ± 0.6
38.3 ± 1.2

23 ± 0.0
36.3 ± 0.6
41.7 ± 2.9

19.2 ± 3.2
34.2 ± 1.8
42.2 ± 1.7
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a vial at 90−100 °C in a mineral oil bath. Once all HA was
dissolved, CEL (2.5 or 5% w/w) was added in 10% increments
to the vial. After CEL dissolved and the solution homogenized,
the mixture was transferred to a silicone mold and placed in a
refrigerator overnight to allow gel formation. The ionic liquid,
[Bmim][Cl], was recovered by soaking the composite in
deionized water. Water was subsequently removed from
[Bmim][Cl] by lyophilization. Conﬁrmation of [Bmim][Cl]
removal was concluded using FT-IR characterization and is
detailed in Figure S1 in the Supporting Information. Silver
nitrate (AgNO3) ion test was also performed to conﬁrm the
removal of all [Bmim][Cl] from the composite. These
composites were cut to size (1.27 cm × 1.27 cm), lyophilized
overnight, and stored on the benchtop. Most notably, no crosslinking agents or chemical modiﬁcations were used in this
synthesis. These HA/CEL-based composites were then
characterized by Fourier transform infrared (FT-IR) spectroscopy, thermogravimetric analysis (TGA), X-ray diﬀraction
(XRD), and scanning electron microscopy (SEM). They were
also evaluated for swelling capacity and drug release properties.
Synthesis and Characterization of ChlorhexidineBased GUMBOS. Chlorhexidine-di cephalothin ([CHX][Ceph]) and chlorhexidine-di oxacillin ([CHX][Oxa]) GUMBOS were synthesized by ion-exchange procedures similar to
those reported in the literature.30 Antibacterial susceptibility to
various multidrug-resistant Gram-negative and Gram-positive
bacteria, as well as cell viability, has been previously reported
by Cole et al.30 These GUMBOS have also been shown to
have increased pharmacokinetic properties, as well as increased
intestinal bioavailability.30
Swelling Capacity. Dried composites were weighed and
soaked in various media, such as 0.9% saline solution, distilled
water, and 1× PBS buﬀer (pH 7.4), at room temperature for
up to 3 h. Weights of the wetted composites were measured at
deﬁned intervals for up to 3 h. Prior to weighing, ﬁlter paper
was wiped across the surface of the composite to remove
excess water. The swelling percent (S%) was determined using
the following equation

this drug through agar.46 Evaluation of data shows that the
porous nature of these biopolymer composites allows for drug
release, and this method of drug delivery has the potential for
minimizing staph infections. Representative images of
incubated agar plates with drug-loaded composites and
standard disks can be found in the Supporting Information
(Figure S17).

■

CONCLUSIONS
In summary, hyaluronic acid/cellulose-based composites were
developed by the dissolution of biopolymers in [Bmim][Cl],
an ionic liquid, with no chemical modiﬁcation. These
composites were developed at two ratios (1:1 and 2:1 HA to
CEL) and showed a variety of morphological and structural
changes that may prove applicable for wound care devices.
Since IL can be removed from the composite material through
washing with water and recovered by lyophilization, this
method is also recyclable. Several spectroscopic and imaging
techniques, including FT-IR, TGA, XRD, and SEM, were used
for characterizing the composite material and monitoring
[Bmim][Cl] recovery. These composites showed great
swelling capacity with the 2:1 composite exhibiting a much
higher capacity. This could translate into an ability to absorb
more wound exudate.
By loading with antimicrobial GUMBOS, these composites
demonstrated their use as possible medicated devices for use in
wound care. When both composites were drop-casted with the
drug, there was uniform coverage on both materials. In drug
release studies, burst release was seen from these composite
materials with a higher release of the drug from 1:1 composite.
Examination of results of in vitro disk diﬀusion tests showed
that both composites allowed the diﬀusion of the drug into the
medium for combating S. aureus infections. These results, in
combination with inherent biocompatibility, strongly suggest
potential biomedical applications of these composites. We will
further investigate (1) the incorporation of drug materials
within the composite network and (2) in vivo wound-healing
properties of these composites using animal models.

■

CHEMICALS AND MATERIALS
Cellulose (medium, ﬁbrous from cotton linters), silver nitrate,
oxacillin sodium salt, and cephalothin sodium salt were
obtained from Sigma-Aldrich. Hyaluronic acid sodium salt
(1.5−2.2 MDa) and chlorhexidine diacetate were obtained
from Acros Organics. 1-Chlorobutane was obtained from Alfa
Aesar. Methylimidazole was obtained from TCI Chemicals. S.
aureus (ATCC 29213) was grown in brain heart infusion
(BHI) broth and subcultured on mannitol salt agar. Inoculates
were prepared in BHI and spread on Mueller−Hinton agar. All
growth media was obtained from Accumedia.

S% =

Ws −Wd
× 100%
Wd

(2)

In eq 2, Wd is the weight of the dried composite and Ws is the
weight of the respective swollen composite. The swelling
percent is deﬁned as the fractional increase in the composite
weight due to absorption. All swelling studies were performed
in triplicate.
Drug Loading. The drugs [CHX][Ceph] and [CHX][Oxa] were dissolved in methanol and diluted to the desired
concentration in 500 μL of methanol. Fifty microliters of the
solution was drop-casted repeatedly onto the composite with
the evaporation of methanol between each loading. It is
presumed that drug loading is 100%. The composite was then
dried overnight using evaporation to ensure complete removal
of methanol.
Drug Release. Composites were placed in vials with 5 mL
of a 0.9% saline solution and were constantly shaken using a
VWR S-500 orbital shaker at room temperature. At ﬁxed time
intervals, 4 mL of a 0.9% saline solution was removed and
replaced with an equal volume of fresh saline to maintain a
constant volume. The amount of drug released was assayed
using a Shimadzu UV-3101PC UV−vis−near-infrared (NIR)

■

EXPERIMENTAL SECTION
Synthesis and Characterization of HA/Cellulose
Composite. Composites were fabricated in various ratios
(1:1, 1:2, 2:1, 1:4, and 4:1) of hyaluronic acid to cellulose and
did not exceed 5% w/w HA. However, 1:1 and 2:1 (HA/CEL)
yielded the most stable composites that did not wash away
upon the removal of [Bmim][Cl]; thus, this manuscript
focuses only on these two ratios. Composites were fabricated
by ﬁrst dissolving sodium hyaluronan (5% w/w) in [Bmim][Cl] and were synthesized according to procedures reported in
the literature by Crowhurst et al.47 The solution was stirred in
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spectrophotometer (Shimadzu Europe) at λ = 231 nm. All
drug release studies were performed in triplicate.
Kirby−Bauer Disk Diﬀusion. Testing was performed
according to the Clinical and Laboratory Standards Institute
(CLSI) recommended procedures. 48 Kirby−Bauer disk
diﬀusion assays44,45 were performed on S. aureus (ATCC
29213) to qualitatively demonstrate that therapeutic agents
can be released from these dry composites and thus could
minimize potential bacterial infections. Before lyophilization,
composites were molded with a 7 mm plastic straw. These
rounds were freeze-dried overnight and subsequently impregnated with therapeutic agents. Controls containing the same
concentration of therapeutic agents were prepared using
standard 6 mm paper disks to eﬀectively compare the bacterial
control relative to the composite. S. aureus was grown in a
brain heart infusion (BHI) medium for 24 h and subcultured
onto mannitol salt agar. Inoculum matching a 1.0 McFarland
standard was prepared in the BHI medium and spread evenly
over the surface of a Mueller−Hinton agar plate to allow a
conﬂuent lawn of growth. Composite rounds and disks were
placed on the agar plate and incubated upside down for 20−24
h at 37 °C. After incubation, zones of inhibition had formed
around the composites and standard disks. Zone diameters
were measured using a ruler. All experiments were performed
in triplicate.
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